InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ProMIS Neurosciences Inc.

PMN Clue Score53
Ontario, Canada Fiscal year ends December CIK 0001374339
$9.61 +5.03% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $9.61 +6,764.29% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2021Operating income−8.3Net income−9.8EPS, diluted−1.69Fiscal year 2022Operating income−23.4Net income−18.1EPS, diluted−2.41Fiscal year 2023Operating income−14.3Net income−13.2EPS, diluted−1.07Fiscal year 2024Operating income−16.8Net income2.8EPS, diluted2.63Fiscal year 2025Operating income−40.2Net income−39.7 −1,529.3%EPS, diluted−22.61
FY2021FY2022FY2023FY2024FY2025
Operating income −8.3 −23.4 −14.3 −16.8 −40.2
Net income −9.8 −18.1 −13.2 2.8 −39.7
Growth −1,529.3%
EPS, diluted −1.69 −2.41 −1.07 2.63 −22.61

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−9.3Capital expenditure−0.0Free cash flow−9.3Fiscal year 2022Operating cash flow−17.0Capital expenditure−0.0Free cash flow−17.0Fiscal year 2023Operating cash flow−10.8Fiscal year 2024Operating cash flow−27.2Fiscal year 2025Operating cash flow−28.1
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −9.3 −17.0 −10.8 −27.2 −28.1
Capital expenditure −0.0 −0.0 n/a n/a n/a
Free cash flow −9.3 −17.0 n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash16.9Total debt3.9Net cash (debt)13.0Shareholders’ equity5.7Debt to equity0.69Fiscal year 2022Cash5.9Shareholders’ equity−1.3Fiscal year 2023Cash12.6Total debt0.0Net cash (debt)12.6Shareholders’ equity3.8Debt to equity0.00Fiscal year 2024Cash13.3Shareholders’ equity16.5Fiscal year 2025Cash6.1Shareholders’ equity−1.3
FY2021FY2022FY2023FY2024FY2025
Cash 16.9 5.9 12.6 13.3 6.1
Total debt 3.9 n/a 0.0 n/a n/a
Net cash (debt) 13.0 n/a 12.6 n/a n/a
Shareholders’ equity 5.7 −1.3 3.8 16.5 −1.3
Debt to equity 0.69 n/a 0.00 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Assets
16.9 5.9 12.6 13.3 6.1
0.0 0.0 n/a n/a n/a
17.7 6.9 13.6 18.9 9.2
Growth −61.0% +96.7% +38.9% −51.4%
Liabilities
3.9 n/a 0.0 n/a n/a
calc 3.9 n/a 0.0 n/a n/a
12.1 8.3 9.9 2.4 10.4
Equity
−62.2 −80.3 −93.5 −90.7 −130.4
5.7 −1.3 3.8 16.5 −1.3
Growth −123.8% +339.3% −107.6%
Per share and net cash
calc 13.0 n/a 12.6 n/a n/a
7.2 8.6 18.9 1.3 2.2
calc 0.79 −0.16 0.20 12.61 −0.58

† The diluted share count jumps at 2023 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.